Antimicrobial Coatings for Medical Devices Market is expected to reach US$ 6.49 Billion by 2031

Metallic Coatings Segment to Lead Antimicrobial Coatings for Medical Devices Market During 2025–2031

According to our new research study named "Antimicrobial Coatings for Medical Devices Market Forecast to 2031 – Global Analysis – by Material, Coating Type, Device Type, Application, and End User," the market was valued at US$ 2.80 billion in 2024 and is projected to reach US$ 6.49 billion by 2031; it is expected to register a CAGR of 13.2% during 2025–2031. Major factors driving the market include the rising prevalence of hospital-acquired infections and the increasing number of surgical procedures. However, the tedious regulatory approval process of antimicrobial coating products hinders the market. Nanotechnology integration is projected to bring new antimicrobial coatings for medical devices market trends in the coming years.

Antimicrobial coatings for medical devices are surface treatments designed to inhibit or kill harmful microorganisms such as bacteria, fungi, and viruses. These coatings prevent the growth of pathogens on medical instruments, reducing the risk of infections in healthcare settings. They are commonly applied to devices such as catheters, surgical tools, and implants. The coatings are often made from silver, copper, or other materials known for their antimicrobial properties, enhancing device longevity, improving patient safety, and reducing the need for frequent sterilization.

Antimicrobial Coatings for Medical Devices Market, by Region, 2025 (%)

Source: The Insight Partners Analysis

The rising cases of healthcare-associated infections (HAIs), increasing demand for safer and more effective medical treatments, and advancements in coating technologies are contributing to the growing antimicrobial coatings for medical devices market size. Increasing awareness about patient safety and infection control, coupled with stricter regulatory requirements, has heightened the demand for such coatings in the manufacturing of equipment meant for installation in hospitals and other healthcare facilities. Technological advancements in materials, including the development of highly effective silver, copper, and nanomaterial-based coatings, have also expanded their application scope and enhanced their effectiveness. Furthermore, the aging global population and the rise in chronic diseases are leading to higher usage of medical devices, such as implants, catheters, and surgical instruments, thereby increasing the need for antimicrobial protection.

Antimicrobial Coatings for Medical Devices Market Analysis Based on Segmental Evaluation:

Based on material, the antimicrobial coatings for medical devices market is categorized into metallic coatings and non-metallic coatings. The metallic coatings segment held significant antimicrobial coatings for medical devices market share in 2024, and it is anticipated to record the fastest CAGR during the forecast period. Metallic coatings are gaining prominence in the medical device industry due to their strong antibacterial properties and effectiveness in minimizing the risk of infections. Metals such as silver, copper, and zinc exhibit inherent antimicrobial characteristics, making them ideal for coating the surfaces of various medical devices, including surgical tools, implants, and protective equipment. Silver, for instance, is known to reduce microbial growth by up to 99.9%, significantly lowering the risk of surgical site infections. Recent advancements in nanotechnology have further enhanced the efficacy of metallic coatings, providing longer-lasting protection and extending their application across a broader range of medical devices.

In terms of device type, the antimicrobial coatings for medical devices market is segmented into catheters, implantable devices, surgical instruments, and others. The implantable devices segment dominated the market in 2024. Antibacterial coatings for implantable devices are essential in reducing the risk of infections, which can lead to serious complications, extended hospital stays, and increased healthcare costs. According to the 2023 HAI data results published in the National Healthcare Safety Network’s (NHSN) HAI Progress Report, there was a 2% increase in the standardized infection ratio (SIR) for all NHSN operative procedure categories combined compared to the ratio recorded in 2022. Additionally, the 2023 data showed a significant 3% rise in the SIR for the Surgical Care Improvement Project (SCIP) NHSN operative procedure categories compared to 2022. The increase is driven by the rising number of implant surgeries and an increase in the focus on infection control in healthcare settings.

Silver-based coatings are common, as they offer broad-spectrum antimicrobial properties. BASF provides Agion, a silver-based coating used in implants such as hip replacements. Zimmer Biomet uses silver ion coatings in joint replacement implants. Stryker's ProPeg is an antimicrobial coating for orthopedic implants. Medtronic offers SilverCoat for vascular stents. Biocoat applies BioCote in implants to reduce infection rates. These coatings are critical in reducing hospital-acquired infections (HAIs) and improving patient outcomes in surgical procedures.

Common implantable devices that are coated with antibacterial agents include orthopedic implants, cardiac devices, and prosthetics. Innovative materials such as silver nanoparticles, graphene, and hydrophilic coatings have shown significant potential in preventing bacterial adhesion and biofilm formation. Further, cost-effectiveness studies reveal that implementing antibacterial coatings could save healthcare systems millions by reducing the incidence of healthcare-associated infections and their associated treatment costs.

The geographic scope of the antimicrobial coatings for medical devices market report includes the assessment of the market performance in North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In terms of revenue, North America dominated the antimicrobial coatings for medical devices market share in 2024. This growth is attributed to the rising prevalence of chronic diseases; an aging population; increasing awareness about HAIs; and surging use of medical devices such as implants, catheters, and surgical instruments. Technological advancements in antimicrobial coating materials and innovations in device design also contribute to the market expansion in this region.

HAIs are a major concern in healthcare facilities in the US, leading to longer hospital stays and increased mortality. Device-associated HAIs (DA-HAIs), such as ventilator-associated pneumonia (VAP), central-line-associated bloodstream infections (CLABSI), and catheter-associated urinary tract infections (CAUTI), cause a significant number of these infections. According to an article published in the Research and Reports in April 2022, up to 80% of complicated urinary tract infections are linked to indwelling urinary catheters in the US. CAUTIs are the most common type of HAIs, accounting for approximately 1 million cases annually in the US. They are also the leading cause of secondary bloodstream infections. Additionally, 3–10% of residents in long-term care facilities are managed with chronic indwelling catheters. The growing use of such catheters may increase the demand for antimicrobial coatings for catheters to prevent CAUTIs.

With the increasing need for medical products that have antimicrobial surfaces, medical device manufacturers in the US are searching for antimicrobial coatings that are biocompatible, biostable, nontoxic, and FDA-standard compliant. Microban, one of the companies headquartered in the US, offers the largest collection of proven antimicrobial technologies that refrain device surfaces from harboring harmful bacterial strains. These cutting-edge formulations can be incorporated into various medical products and surfaces to enhance their antimicrobial attributes and reduce the spread of HAIs, thereby contributing significantly to the antimicrobial coatings for medical devices market growth in North America.

Additionally, various local players have actively developed innovative antimicrobial coatings for medical devices, which bolsters the antimicrobial coatings for medical devices market growth. In August 2020, a team of scientists at the Department of Molecular Genetics at the University of Toronto tested an antimicrobial coating capable of deactivating more than 99% of SARS-CoV-2 on the outer surface of medical masks. The product is developed by I3 Biomedical, a Canadian company headquartered in Mirabel.

The Sherwin-Williams Co, PPG Industries Inc., CytaCoat AB, Covalon Technologies Ltd, Koninklijke DSM NV, Specialty Coating Systems Inc., AST Products Inc., Hydromer Inc., BioInteractions Ltd, and Spartha medical SAS are among the leading companies profiled in the antimicrobial coatings for medical devices market report.

Based on material, the antimicrobial coatings for medical devices market is categorized into metallic coatings and non-metallic coatings. By coating type, the market is segmented into antibacterial coatings, antiviral coatings, and others. In terms of device type, the antimicrobial coatings for medical devices market is segmented into catheters, implantable devices, surgical instruments, and others. Based on application, the market is segmented into general surgery, cardiovascular, orthopedics, gynecology, dentistry, and others. By end user, the antimicrobial coatings for medical devices market is segmented into medical device manufacturers, contract manufacturers, and service providers. Geographically, the market is categorized into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com